Brain 17 Vienna
PROFILE trial 1014 (crizotinib vs chemotherapy) intracranial progression free survival of pts with treated BM
Crizotinib
Chemotherapy
Brain metastases in patients with ALK-positive NSCLC
BM - brain metastases
Solomon et al 2016, J Clin Oncol; 34 (24), 2858-65
Made with FlippingBook - Online catalogs